+(90) (312)-447-0274

Mon - Fri 08:30am - 05:30pm

info@klinar-cro.com

Follow Us on Social:
 

History

2020

Project Status

Our companies has conducted 423 studies until May 2020. 224 of these studies were International Studies and 199 of them were local studies conducted in Turkey.

2020

Approval Timelines

For our 125 studies conducted in the last 5 years: The approval timelines for the Ethics Commitee for the initial submission is 23 days The approval timelines for the Ministry of Health for the initial submission is 33 days.

2020

SIV and FPI Statistics

For our 125 studies conducted in the las 5 years: The first site initiation time from the Ministry of Health approval is 38 days on average. The first patient in (FPI) time after the first site initiation is 16 days on average.

2020

Enrollment Targets

During the last 5 year in our 125 projects conducted, 88 of these 125 studies has reached the target enrollment.

2021

Project Status

Our companies has conducted 444 studies until Feb 2021. 233 of these studies were International Studies and 211 of them were local studies conducted in Turkey.

2021

Approval Timelines

For our 133 studies conducted in the last 5 years: The approval timelines for the Ethics Commitee for the initial submission is 23 days The approval timelines for the Ministry of Health for the initial submission is 33 days.

2021

SIV and FPI Statistics

For our 125 studies conducted in the las 5 years: The first site initiation time from the Ministry of Health approval is 27 days on average. The first patient in (FPI) time after the first site initiation is 16 days on average.

2021

Enrollment Targets

During the last 5 year in our 125 projects conducted, 95 of these 125 studies has reached the target enrollment.

2021

In Conclusion with Klinar's leading experience

Turkey is a very good country for clinical trials because of: - Having very good sites - With enthusiastic, experienced site staff - Start-up timelines are reasonable - Has a very good pool of patients even for the rare disease - The prices are reasonable comparing to the other countries

2022

Project Status

Our companies has conducted 503 studies until December 2022. 279 of these studies were International Studies and 224 of them were local studies conducted in Turkey.

2022

Approval Timelines

For our 101 studies conducted in the last 5 years: The approval timelines for the Ethics Commitee for the initial submission is 35 days The approval timelines for the Ministry of Health for the initial submission is 102 days.

2022

SIV and FPI Statistics

For our 101 studies conducted in the las 5 years: The first site initiation time from the Ministry of Health approval is 73 days on average. The first patient in (FPI) time after the first site initiation is 55 days on average.

2022

Enrollment Targets

During the last 5 year in our 101 projects conducted, 79 of these 101 studies has reached the target enrollment.

2023

Project Status

Our companies has conducted 519 studies until December 2023. 287 of these studies were International Studies and 232 of them were local studies conducted in Turkey.

2023

Approval Timelines

TFor our 106 studies conducted in the last 5 years: The approval timelines for the Ethics Commitee for the initial submission is 35 days The approval timelines for the Ministry of Health for the initial submission is 94 days.

2023

SIV and FPI Statistics

For our 106 studies conducted in the last 5 years: The first site initiation time from the Ministry of Health approval is 89 days on average. The first patient in (FPI) time after the first site initiation is 57 days on average.

2023

Enrollment Targets

During the last 5 year in our 106 projects conducted, 49 of these 106 studies has reached the target enrollment.

Designing and Regulatory Affairs

Monitoring and Project Management

Training Services

Data Management and Analysis

Translation and Publication

Safety Management

Clinical Drug Studies

Klinar CRO has its clinical drug studies history varying from phase I to IV studies.

Observational Studies

Klinar is working on late phase studies such as pharmacovigilance follow-up studies, post-marketing survelliance studies, large scale registry studies, practice pattern studies.

Site Management Organization

Klinar also offers solutions for managing your clinical trials inside level.

Compassionate Use

Klinar CRO has the ability to manage compassionate use studies both in project level and patient level.

Patient Follow-Up Studies

Klinar offers private solutions for tracking systems for your products requiring special follow-up in terms of pharmacovigilance, patient call management by using customer oriented electronic systems and call centers.

Medical Device Studies

Medical device studies for in vivo and in vitro medical devices with or without CE mark is within Klinar's expertise.

Start-Up Activities

Feasibility assesments and start-up expertise sharing for new clients requesting to know more about Turkey's infrastructure is available in Klinar's expertise.

Regulatory Submissions Support

Klinar can support you for all your regulatory submissions in terms of ethics committee and regulatory authority submissions including contract management.

We Have Great Skills

Klinar CRO has a wide range of experience in different therapeutic areas.
Different types of trials such as; Clinical Trials, Post Marketing Trials, Site Management Organization, Electronic Data Capture, ATMP studies, Medical Device Studies and Compassionate Use are being conducted by Klinar CRO.

  • Clinical Drug Studies

  • Observation Studies

  • Other Studies

Get Your Quote or Call: +(90) (312)-447-0274

For clear strategies for your project with flexible, professional, proactive teamwork with competitive costs.